Food and Drug Administration (FDA)-approved chemotherapy medications used for off-label malignancies or indications are covered if they are listed in the Health Net Injectable Protocol Guidelines, or if evidence is presented that the medication is used in treatment for a particular neoplasm under a professionally recognized standard of care, such as an official medication compendium (for example, AHFS Drug Information), or in the bulletin published by the Association of Community Cancer Centers.